Covered recipient · General Payments record
BERONICA B SIMPSON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2023
$740.55
- Reported across 20 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $677.59 | 17 |
| Education | $13.08 | 1 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $238.36 | 6 |
| Amgen Inc. | $191.80 | 5 |
| ABBVIE INC. | $118.55 | 5 |
| Janssen Biotech, Inc. | $112.66 | 1 |
| GlaxoSmithKline, LLC. | $29.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $32.37 | 01/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009821145 | CMS |
| ABBVIE INC. | $14.46 | 02/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009821149 | CMS |
| ABBVIE INC. | $29.99 | 03/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009821153 | CMS |
| ABBVIE INC. | $19.48 | 10/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009821157 | CMS |
| ABBVIE INC. | $22.25 | 12/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009821161 | CMS |
| Amgen Inc. | $28.41 | 02/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020249977 | CMS |
| Amgen Inc. | $5.43 | 02/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020249989 | CMS |
| Amgen Inc. | $110.42 | 03/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020249993 | CMS |
| Amgen Inc. | $27.23 | 06/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020249981 | CMS |
| Amgen Inc. | $20.31 | 06/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020249985 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.08 | 02/02/2023 | Education | Undisputed | 01/23/2026 | 1011638479 | CMS |
| AstraZeneca Pharmaceuticals LP | $110.42 | 03/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015294731 | CMS |
| AstraZeneca Pharmaceuticals LP | $45.02 | 03/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014159055 | CMS |
| AstraZeneca Pharmaceuticals LP | $24.31 | 04/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015109543 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.02 | 05/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015897417 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.51 | 07/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015324603 | CMS |
| GlaxoSmithKline, LLC. | $29.30 | 02/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1004315071 | CMS |
| Janssen Biotech, Inc. | $112.66 | 04/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988118617 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023
- Source files
- Dataset page · Bulk file · PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.